You just read:

Sound Biologics Announces FDA Allowance of its IND Application for PSB205, an Anti-PD-1/CTLA-4 MabPair, in Relapsed and Refractory Solid Tumors

News provided by

Sound Biologics

Apr 10, 2019, 07:30 ET